8-KThe WireRoutine
Reg FD Disclosure
Filed Feb 1, 2024 · 2y ago · Accession 0000950170-24-009776
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Intellia Therapeutics, Inc.
- Ticker
- NTLA
- CIK
- 1652130
- Form type
- 8-K
- Filing date
- Feb 1, 2024
- Report date
- Jan 31, 2024
- Document
- ntla-20240131.htm
- Size
- 204 KB